DMT for Depression in Adults

Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans

Recruiting Phase 1 Interventional Study
Major Depression Disorder Depression
Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 65
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Other
Participants needed
60 (estimated)
Sponsor
Deepak C. D'Souza · Other
Who this trial is looking for

This trial is looking for adults aged 21 to 65 who have depression or are healthy. Participants will take DMT and help researchers understand its effects on mood and brain activity.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 21 and 65 years old.
  • I have a body mass index (BMI) between 18-35.
  • I am willing to avoid medications not approved by the study doctor.
  • I do not use street drugs or alcohol.
  • I have a major depressive disorder and did not respond well to antidepressants.
  • I am receiving treatment for depression and will continue during the study.
  • I agree to allow the research team to communicate with my mental health provider.
  • I will use effective birth control if I am sexually active and able to get pregnant.

You may not be able to join if

  • I have significant problems with blood pressure.
  • I am currently pregnant or breastfeeding.
  • I have a history of substance use disorder.
  • I have a current psychiatric disorder other than major depression.
  • I have had significant cardiovascular disease.
  • I have cognitive dysfunction that affects my ability to participate.
  • I have any unstable medical conditions.
  • I have a history of serotonin syndrome.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The goal of this phase 1 study is to investigate the safety and efficacy of dimethyltryptamine (DMT) in individuals with depression and healthy controls. We hypothesize that administration of DMT will result in decreases in depression, associated symptoms, and neuroplastic changes in depressed subjects. We expect that DMT will induce changes in neuroplasticity as indexed using electroencephalograp…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Some Common Inclusion Criteria: 1. Males and females 2. Age 21 to 65 years 3. Body mass index between 18-35 kg/m2 4. Willing to refrain from taking any medications not approved by the study physician 5. Willing to refrain from using street drugs and alcohol 6. Negative urine drug screen 7. Willing …
Contacts

Deepak C D'Souza, MD

(203) 932-5711

deepak.dsouza@yale.edu

CONTACT